鄰近類別 期刊論文 [3/3] 類別統計 近3年內發表的文件:0(0.00%) 含全文筆數:1(33.33%) 文件下載次數統計 下載大於0次:1(100.00%) 下載大於100次:1(100.00%) 檔案下載總次數:495(9.55%) 最後更新時間: 2024-12-01 08:23 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Results of Phase II trial of AUY922... KRAS mutation status-stratified ran... Impact of ROS1, ALK, and/or MET exp...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-3 / 3. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2016-02	Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 134.
2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
2013-05	KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018.

顯示項目1-3 / 3. (共1頁) 1  每頁顯示[10|25|50]項目